Literature DB >> 30924678

Changes in liver morphology in patients with extrahepatic portal venous obstruction: a retrospective magnetic resonance imaging study.

Pankaj Gupta1, Naveen Kalra2, Ajay Gulati2, Karamvir Chandel2, Prashant Priyaranjan2, Prajwal Dahal2, Saroj K Sinha1, Ajay Duseja3, Radha K Dhiman3, Manavjit Singh Sandhu2.   

Abstract

OBJECTIVE: To investigate the liver parenchymal changes on MRI in patients with extrahepatic portal venous obstruction (EHPVO).
METHODS: This was a retrospective evaluation of the MRI studies in patients with EHPVO between January 2016 and April 2018. The diagnosis of EHPVO in each case had been established on the basis of clinical and Doppler parameters. Following findings were recorded on MRI: liver size; outline; overall volume redistribution; volume redistribution of caudate, right and left lobes; signal heterogeneity, intrahepatic biliary radicle dilatation, focal liver lesions, gallstones and ascites.
RESULTS: A total of 164 MRI studies were evaluated. Median age was 27 years (range, 6-70). There were 90 (54.9%) males and 74 (45.1%) females. The median liver size was 14 cm (range 5-17). The median spleen size was 15.9 cm (range, 6-28). A spleen size ≥12 cm was seen in 136 (82.9%) patients. The liver outline was nodular in 32 (19.5%) patients. Volume redistribution was seen in 63 (38.4%) patients. Caudate lobe hypertrophy was seen in 49 (29.9%) patients. Right lobe atrophy and hypertrophy was seen in 4 (2.4%) and 1 (0.6%) patients respectively. Left lobe atrophy and hypertrophy was seen in 15 (9.1%) and 10 (6.1%) patients respectively. 30 MRI (18.3%) showed heterogeneous signal intensity. Focal lesions were seen in 22 (13.4%) patients. Intrahepatic biliary radicle dilatation, gallstones and ascites were seen in 120 (73.2%), 54 (32.9%) and 26 (15.9%) patients respectively.
CONCLUSION: Liver morphological changes are common in EHPVO. ADVANCES IN KNOWLEDGE: The morphological changes in liver in patients with EHPVO have not been described previously. This information will prevent misdiagnosis of this condition as cirrhosis.

Entities:  

Mesh:

Year:  2019        PMID: 30924678      PMCID: PMC6592076          DOI: 10.1259/bjr.20180890

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

Review 1.  Imaging of portal cavernoma cholangiopathy.

Authors:  Naveen Kalra; Shiva Shankar; Niranjan Khandelwal
Journal:  J Clin Exp Hepatol       Date:  2013-09-27

Review 2.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2015-06-03       Impact factor: 25.083

Review 4.  Natural history of portal cavernoma cholangiopathy.

Authors:  Manoj Kumar; Vivek A Saraswat
Journal:  J Clin Exp Hepatol       Date:  2013-08-27

5.  Multimodality imaging of primary extrahepatic portal vein obstruction (EHPVO): what every radiologist should know.

Authors:  A Arora; S K Sarin
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

6.  Liver and spleen stiffness in patients with extrahepatic portal vein obstruction.

Authors:  Praveen Sharma; Smruti Ranjan Mishra; Manoj Kumar; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Radiology       Date:  2012-04-20       Impact factor: 11.105

7.  Increased frequency of gallstones in cirrhotic and non-cirrhotic portal hypertension.

Authors:  S K Sarin; R C Guptan; Shailaja Malhotra
Journal:  J Assoc Physicians India       Date:  2002-04

8.  Cirrhosis: modified caudate-right lobe ratio.

Authors:  Hitomi Awaya; Donald G Mitchell; Tamotsu Kamishima; George Holland; Katsuyoshi Ito; Tsuneo Matsumoto
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

Review 9.  Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Authors:  Jasper H Smalberg; Lidia R Arends; Dominique C Valla; Jean-Jacques Kiladjian; Harry L A Janssen; Frank W G Leebeek
Journal:  Blood       Date:  2012-10-04       Impact factor: 22.113

10.  Clinical and laboratory differentiation of cirrhosis and extrahepatic portal venous obstruction in children.

Authors:  Lorance Peter; Sunil Kumar Dadhich; Surender Kumar Yachha
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

View more
  2 in total

1.  Benign Hepatic Nodules in Patients With Primary Extrahepatic Portal Vein Obstruction: Clinical and Magnetic Resonance Imaging Features.

Authors:  Kapil Semalti; Ragini Kilambi; Sujoy Pal; Deep N Srivastava; Peush Sahni; Kumble S Madhusudhan
Journal:  J Clin Exp Hepatol       Date:  2022-04-20

2.  Evaluation of Platelet Indices in Patients with Splanchnic Vein Thrombosis.

Authors:  Saniya Sharma; Narender Kumar; Ishwar Bihana; Varun Uppal; Jasmina Ahluwalia; Shano Naseem; Neelam Varma; Surinder Singh Rana
Journal:  Indian J Hematol Blood Transfus       Date:  2021-04-13       Impact factor: 0.915

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.